delivered SaKKH-BE3 through intravenous injection of dual-AAV plasmids into a PKU mouse model to restore phenylalanine hydroxylase (PAH) enzyme activity and revert the light fur phenotype in these animals (117). Here, PAH is linked to phenylketonuria.